Cargando…

2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1

BACKGROUND: Influenza-like illnesses (ILI) are common in military populations due to close living and working conditions, physical exertion, and exposure to novel viruses. The PAIVED trial aims to compare the effectiveness of 3 FDA approved influenza vaccines in active-duty military, retiree, and de...

Descripción completa

Detalles Bibliográficos
Autores principales: Schofield, Christina, Richard, Stephanie, Colombo, Rhonda, Collins, Limone, Ganesan, Anuradha, Geaney, Casey, Lalani, Tahaniyat, Markelz, Ana E, Maves, Ryan, Mende, Katrin, Seshadri, Srihari, Spooner, Christina, Utz, Gregory, Warkentien, Tyler, Coles, Christian L, Burgess, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809891/
http://dx.doi.org/10.1093/ofid/ofz360.2477
_version_ 1783462108630876160
author Schofield, Christina
Richard, Stephanie
Colombo, Rhonda
Collins, Limone
Ganesan, Anuradha
Geaney, Casey
Lalani, Tahaniyat
Markelz, Ana E
Maves, Ryan
Mende, Katrin
Seshadri, Srihari
Spooner, Christina
Utz, Gregory
Warkentien, Tyler
Coles, Christian L
Burgess, Timothy
author_facet Schofield, Christina
Richard, Stephanie
Colombo, Rhonda
Collins, Limone
Ganesan, Anuradha
Geaney, Casey
Lalani, Tahaniyat
Markelz, Ana E
Maves, Ryan
Mende, Katrin
Seshadri, Srihari
Spooner, Christina
Utz, Gregory
Warkentien, Tyler
Coles, Christian L
Burgess, Timothy
author_sort Schofield, Christina
collection PubMed
description BACKGROUND: Influenza-like illnesses (ILI) are common in military populations due to close living and working conditions, physical exertion, and exposure to novel viruses. The PAIVED trial aims to compare the effectiveness of 3 FDA approved influenza vaccines in active-duty military, retiree, and dependent populations, and will also provide information about the burden, impact, and severity of ILI. METHODS: Participants were enrolled in the 2018–2019 influenza season at 5 geographically diverse military facilities. Active duty, non-recruit military personnel, retirees, and dependents were randomized to receive influenza vaccine (egg-based, recombinant, or cell-culture derived) and then completed weekly electronic surveys throughout the influenza season. If a participant reported ILI symptoms during surveillance, 2 in-person visits with study personnel were scheduled for confirmed ILI. Nasal swabs and blood samples were collected for diagnostic and immunologic testing. RESULTS: Among the 852 non-recruit participants enrolled in PAIVED, 25% were active military, 36% retired military, and 39% dependents. Almost half (48%) were female, and 72% were white, 15% African American, 6% Asian, 4% multiple races, and 3% unknown or other race. 788 participants (92%) responded to at least one surveillance questionnaire. Participants reported 407 ILIs (Figure 1), of which 160 met the study case definition. Between 12 and 28% of the participants experienced an ILI during the surveillance period, and 12 people experienced 2 ILIs. Most sites reported a median 2–3 days of fever/feverishness or chills and 3–4 days of reduced activity associated with an ILI episode. No viruses were detected in 58% of nasal swabs, 1 virus in 40%, and 2 viruses in 1% of swabs (Figure 2 for pathogen data). CONCLUSION: During the period under study, ILIs were common with 1 in 6 participants experiencing a confirmed ILI, many of which were 6–8 days in duration. ILIs resulted in reduced activity, although few individuals reported missing work or school, a situation that could result in greater likelihood of transmission to others. Planned analyses will provide additional information about the pathogens responsible for these illnesses and help guide effective prevention policies in these populations. [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6809891
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68098912019-10-28 2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1 Schofield, Christina Richard, Stephanie Colombo, Rhonda Collins, Limone Ganesan, Anuradha Geaney, Casey Lalani, Tahaniyat Markelz, Ana E Maves, Ryan Mende, Katrin Seshadri, Srihari Spooner, Christina Utz, Gregory Warkentien, Tyler Coles, Christian L Burgess, Timothy Open Forum Infect Dis Abstracts BACKGROUND: Influenza-like illnesses (ILI) are common in military populations due to close living and working conditions, physical exertion, and exposure to novel viruses. The PAIVED trial aims to compare the effectiveness of 3 FDA approved influenza vaccines in active-duty military, retiree, and dependent populations, and will also provide information about the burden, impact, and severity of ILI. METHODS: Participants were enrolled in the 2018–2019 influenza season at 5 geographically diverse military facilities. Active duty, non-recruit military personnel, retirees, and dependents were randomized to receive influenza vaccine (egg-based, recombinant, or cell-culture derived) and then completed weekly electronic surveys throughout the influenza season. If a participant reported ILI symptoms during surveillance, 2 in-person visits with study personnel were scheduled for confirmed ILI. Nasal swabs and blood samples were collected for diagnostic and immunologic testing. RESULTS: Among the 852 non-recruit participants enrolled in PAIVED, 25% were active military, 36% retired military, and 39% dependents. Almost half (48%) were female, and 72% were white, 15% African American, 6% Asian, 4% multiple races, and 3% unknown or other race. 788 participants (92%) responded to at least one surveillance questionnaire. Participants reported 407 ILIs (Figure 1), of which 160 met the study case definition. Between 12 and 28% of the participants experienced an ILI during the surveillance period, and 12 people experienced 2 ILIs. Most sites reported a median 2–3 days of fever/feverishness or chills and 3–4 days of reduced activity associated with an ILI episode. No viruses were detected in 58% of nasal swabs, 1 virus in 40%, and 2 viruses in 1% of swabs (Figure 2 for pathogen data). CONCLUSION: During the period under study, ILIs were common with 1 in 6 participants experiencing a confirmed ILI, many of which were 6–8 days in duration. ILIs resulted in reduced activity, although few individuals reported missing work or school, a situation that could result in greater likelihood of transmission to others. Planned analyses will provide additional information about the pathogens responsible for these illnesses and help guide effective prevention policies in these populations. [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809891/ http://dx.doi.org/10.1093/ofid/ofz360.2477 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Schofield, Christina
Richard, Stephanie
Colombo, Rhonda
Collins, Limone
Ganesan, Anuradha
Geaney, Casey
Lalani, Tahaniyat
Markelz, Ana E
Maves, Ryan
Mende, Katrin
Seshadri, Srihari
Spooner, Christina
Utz, Gregory
Warkentien, Tyler
Coles, Christian L
Burgess, Timothy
2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1
title 2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1
title_full 2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1
title_fullStr 2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1
title_full_unstemmed 2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1
title_short 2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1
title_sort 2800. pragmatic assessment of influenza vaccine effectiveness in the dod (paived): influenza-like-illness rates in year 1
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809891/
http://dx.doi.org/10.1093/ofid/ofz360.2477
work_keys_str_mv AT schofieldchristina 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT richardstephanie 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT colomborhonda 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT collinslimone 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT ganesananuradha 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT geaneycasey 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT lalanitahaniyat 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT markelzanae 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT mavesryan 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT mendekatrin 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT seshadrisrihari 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT spoonerchristina 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT utzgregory 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT warkentientyler 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT coleschristianl 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1
AT burgesstimothy 2800pragmaticassessmentofinfluenzavaccineeffectivenessinthedodpaivedinfluenzalikeillnessratesinyear1